Related Experiment Videos
[Integrins and integrin-associated molecules: targets for the development of antimetastatic therapies]
M A Velasco-Velázquez1, J A Molina-Guarneros, N Mendoza-Patiño
1Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), México, D.F. marcovelasco@hotmail.com
Abstract:
Integrins are receptors that mediate cell adhesion and the formation of signaling complex. Changes in the expression of integrins are required during the following steps in the generation of metastases: a) angiogenesis; b) detachment from the primary tumor; c) tumor cell-platelet interaction; d) adhesion to vascular endothelium and e) proliferation. There is a correlation between invasive capability and changes in the expression of some proteins that are clustered in focal adhesion sites, as FAK, CD82, CD9 or CD63. Both, integrin blocking (using antibodies or RGD containing peptides), as well as induced changes in the expression of integrin-associated molecules, are able to inhibit formation of metastases. Discovery and characterization of molecules that regulate the adhesive capability of tumor cells, will lead to development of antimetastasic therapies. In the search of tumor dissemination inhibitors, integrins and some integrin-associated molecules are important pharmacological targets.
Insights
Integrins mediate cell adhesion and are crucial for metastasis formation. Targeting integrins and associated molecules offers a promising strategy for developing anti-metastatic therapies.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Context:
- Integrins are cell surface receptors vital for cell adhesion and intracellular signaling.
- Metastasis involves multiple steps including angiogenesis, detachment, circulation, and extravasation.
- Altered integrin expression correlates with tumor cell invasiveness.
Purpose:
- To explore the role of integrins in the multi-step process of metastasis.
- To identify integrin-associated molecules as potential therapeutic targets for inhibiting cancer spread.
Summary:
- Integrin expression changes are essential for key metastatic events like angiogenesis, tumor cell detachment, and adhesion to endothelium.
- Proteins in focal adhesion sites, such as FAK, CD82, CD9, and CD63, show altered expression correlating with invasiveness.
- Blocking integrins or modulating associated molecules can inhibit metastasis formation.
Impact:
- Highlights integrins and associated molecules as critical pharmacological targets for anti-metastatic drug development.
- Understanding integrin-mediated adhesion may lead to novel strategies to prevent cancer dissemination.
- This research could pave the way for more effective treatments against metastatic cancer.